BACKGROUND AND AIMS: Endothelial progenitor cells (EPCs) are bone marrow derived pluripotent vascular progenitor cells capable to contribute to re-endothelialization and neovascularization. The number of circulating EPCs has been established as a biomarker of cardiovascular risk and is known to decrease with age. We determined the number of EPCs in teenagers and evaluated the influence of traditional risk factors focusing on overweight. METHODS: 79 male adolescents were enrolled (age 13-17 years; 42 of normal weight: 64.1 +/- 7.6 kg; 37 above the 90th BMI-percentile: 96.9 +/- 20.5 kg). 41 healthy adults served as controls. EPCs were counted by flow cytometry (CD34+/-CD133/KDR). Besides traditional risk factors, cholesterol, and high sensitive CRP different cytokines were determined. RESULTS: Overweight adolescents have a higher systolic blood pressure, higher hsCRP, higher HbA(1c) and lower HDL. The number of CD34-negative EPCs, but not CD34-positive EPCs is higher in overweight adolescents. The overall level of EPCs is lower in adolescents compared to adults. CONCLUSIONS: Overweight in adolescents influences EPCs in early life. CD34-negative EPCs might be more sensitive to the early risk profile and may represent a biological marker of occult vascular damage. Beginning insulin resistance, endothelial damage and elevation of EPCs could indicate the higher risk for future cardiovascular disease in obese teenagers.
BACKGROUND AND AIMS: Endothelial progenitor cells (EPCs) are bone marrow derived pluripotent vascular progenitor cells capable to contribute to re-endothelialization and neovascularization. The number of circulating EPCs has been established as a biomarker of cardiovascular risk and is known to decrease with age. We determined the number of EPCs in teenagers and evaluated the influence of traditional risk factors focusing on overweight. METHODS: 79 male adolescents were enrolled (age 13-17 years; 42 of normal weight: 64.1 +/- 7.6 kg; 37 above the 90th BMI-percentile: 96.9 +/- 20.5 kg). 41 healthy adults served as controls. EPCs were counted by flow cytometry (CD34+/-CD133/KDR). Besides traditional risk factors, cholesterol, and high sensitive CRP different cytokines were determined. RESULTS: Overweight adolescents have a higher systolic blood pressure, higher hsCRP, higher HbA(1c) and lower HDL. The number of CD34-negative EPCs, but not CD34-positive EPCs is higher in overweight adolescents. The overall level of EPCs is lower in adolescents compared to adults. CONCLUSIONS: Overweight in adolescents influences EPCs in early life. CD34-negative EPCs might be more sensitive to the early risk profile and may represent a biological marker of occult vascular damage. Beginning insulin resistance, endothelial damage and elevation of EPCs could indicate the higher risk for future cardiovascular disease in obese teenagers.
Authors: Thomas J Wang; Philimon Gona; Martin G Larson; Daniel Levy; Emelia J Benjamin; Geoffrey H Tofler; Paul F Jacques; James B Meigs; Nader Rifai; Jacob Selhub; Sander J Robins; Christopher Newton-Cheh; Ramachandran S Vasan Journal: Hypertension Date: 2007-01-22 Impact factor: 10.190
Authors: Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal Journal: JAMA Date: 2006-04-05 Impact factor: 56.272
Authors: B Daan Westenbrink; Erik Lipsic; Peter van der Meer; Pim van der Harst; Hisko Oeseburg; Gideon J Du Marchie Sarvaas; Johan Koster; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst; Regien G Schoemaker Journal: Eur Heart J Date: 2007-06-17 Impact factor: 29.983
Authors: Andreas Alexander Meyer; Günther Kundt; Michael Steiner; Peter Schuff-Werner; Wolfgang Kienast Journal: Pediatrics Date: 2006-05 Impact factor: 7.124
Authors: Katherine A Gallagher; Zhao-Jun Liu; Min Xiao; Haiying Chen; Lee J Goldstein; Donald G Buerk; April Nedeau; Stephen R Thom; Omaida C Velazquez Journal: J Clin Invest Date: 2007-05 Impact factor: 14.808
Authors: Daniel J Ceradini; Anita R Kulkarni; Matthew J Callaghan; Oren M Tepper; Nicholas Bastidas; Mark E Kleinman; Jennifer M Capla; Robert D Galiano; Jamie P Levine; Geoffrey C Gurtner Journal: Nat Med Date: 2004-07-04 Impact factor: 53.440
Authors: Noora Mattsson; Tapani Rönnemaa; Markus Juonala; Jorma S A Viikari; Eero Jokinen; Nina Hutri-Kähönen; Mika Kähönen; Tomi Laitinen; Olli T Raitakari Journal: Eur Heart J Date: 2007-12-15 Impact factor: 29.983
Authors: David M Leistner; Ulrich Fischer-Rasokat; Jörg Honold; Florian H Seeger; Volker Schächinger; Ralf Lehmann; Hans Martin; Iris Burck; Carmen Urbich; Stefanie Dimmeler; Andreas M Zeiher; Birgit Assmus Journal: Clin Res Cardiol Date: 2011-06-03 Impact factor: 5.460
Authors: Christoph Edlinger; Catharina Schreiber; Bernhard Wernly; Alexandra Anker; Katja Ruzicka; Christian Jung; Uta C Hoppe; Michael Lichtenauer Journal: Stem Cell Rev Rep Date: 2015-10 Impact factor: 5.739
Authors: V J Karthikeyan; Andrew D Blann; Sabah Baghdadi; Deirdre A Lane; D Gareth Beevers; Gregory Y H Lip Journal: Clin Res Cardiol Date: 2011-01-09 Impact factor: 5.460
Authors: Andreas Rolf; Birgit Assmus; Volker Schächinger; Johannes Rixe; Susanne Möllmann; Helge Möllmann; Stefanie Dimmeler; Andreas M Zeiher; Christian W Hamm; Thorsten Dill Journal: Clin Res Cardiol Date: 2011-06-17 Impact factor: 5.460
Authors: Luc Bruyndonckx; Vicky Y Hoymans; Amaryllis H Van Craenenbroeck; Dirk K Vissers; Christiaan J Vrints; José Ramet; Viviane M Conraads Journal: Oxid Med Cell Longev Date: 2013-04-03 Impact factor: 6.543